Literature DB >> 11202230

Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients.

I J Sørensen1, E Holm Nielsen, L Schrøder, A Voss, L Horváth, S E Svehag.   

Abstract

Serum amyloid P component (SAP) binds in vitro to DNA; based on findings in SAP-deficient mice it was proposed that SAP's role is to handle chromatin and DNA, thereby preventing formation of anti-DNA antibodies. For the first time we have shown the presence of Ca2+-dependent SAP-DNA complexes, measured by ELISA, in sera from both healthy volunteers and systemic lupus erythematosus patients (SLE). The concentration of SAP-DNA complexes in SLE sera was significantly lower than in normal sera and particularly low in sera from patients with anti-DNA titers exceeding 50. The complexes were dissociated by the SAP ligand heparin and were not demonstrable in EDTA plasma. Normal sera showed similar capacity to form SAP-DNA complexes with both thymus and Escherichia coli DNA, whereas significantly lower amounts of complexes, in particular with E. coli DNA, were formed in SLE sera. SLE patients with moderate to high anti-DNA titers showed a significant negative correlation between serum SAP's binding of E. coli DNA and the anti-DNA titer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11202230     DOI: 10.1023/a:1026478914129

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  21 in total

Review 1.  The role of bacterial DNA in autoantibody induction.

Authors:  D S Pisetsky
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  A novel peptide from amyloid P component supports cell attachment.

Authors:  S Dhawan; R L Fields; F A Robey
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

3.  Antigen DNA isolated from immune complexes in plasma of patients with systemic lupus erythematosus hybridizes with the Escherichia coli lac Z gene.

Authors:  K Terada; E Okuhara; Y Kawarada
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

4.  The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice.

Authors:  R W Burlingame; M A Volzer; J Harris; T W Du Clos
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

5.  Complement activation by the amyloid proteins A beta peptide and beta 2-microglobulin.

Authors:  M Nybo; E H Nielsen; S E Svehag
Journal:  Amyloid       Date:  1999-12       Impact factor: 7.141

Review 6.  Systemic lupus erythematosus.

Authors:  B L Kotzin
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

7.  Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli.

Authors:  M B Pepys; S E Booth; G A Tennent; P J Butler; D G Williams
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Demonstration of extrinsic DNA from immune complexes in plasma of a patient with systemic lupus erythematosus.

Authors:  K Terada; E Okuhara; Y Kawarada; S Hirose
Journal:  Biochem Biophys Res Commun       Date:  1991-01-15       Impact factor: 3.575

9.  Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus.

Authors:  A McCoubrey-Hoyer; T B Okarma; H R Holman
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

10.  Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus.

Authors:  S M Breathnach; H Kofler; N Sepp; J Ashworth; D Woodrow; M B Pepys; H Hintner
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  4 in total

1.  Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.

Authors:  G Zandman-Goddard; M Blank; P Langevitz; L Slutsky; M Pras; Y Levy; O Shovman; T Witte; A Doria; J Rovensky; Y Shoenfeld
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

2.  Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.

Authors:  M Bijl; H Bootsma; Y Van Der Geld; P C Limburg; C G M Kallenberg; M H Van Rijswijk
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

3.  Amelioration of lupus nephritis by serum amyloid P component gene therapy with distinct mechanisms varied from different stage of the disease.

Authors:  Weijuan Zhang; Jin Wu; Bin Qiao; Wei Xu; Sidong Xiong
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

Review 4.  Functional Reciprocity of Amyloids and Antimicrobial Peptides: Rethinking the Role of Supramolecular Assembly in Host Defense, Immune Activation, and Inflammation.

Authors:  Ernest Y Lee; Yashes Srinivasan; Jaime de Anda; Lauren K Nicastro; Çagla Tükel; Gerard C L Wong
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.